Press release
United States Injectable Drug Delivery Market to hit US$ 1258.4 million by 2033 | Top Companies are Becton Dickinson & Company, Baxter International, Inc, Gerresheimer AG, Pfizer Inc, Schott AG
Injectable Drug Delivery Market
DataM Intelligence has released its latest report on the "Injectable Drug Delivery Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.
Taisho Pharmaceutical Co., Ltd. launched the Nanozora 30mg autoinjector for subcutaneous injection, a single-use, prefilled device containing the same TNFα inhibitor as its syringe form In January 2024
United States: Recent Industry Developments
✅ October 2025: Becton Dickinson introduced advanced prefilled syringes with enhanced safety features for biologic drugs.
✅ September 2025: Pfizer expanded its portfolio of injectable therapies supported by innovative delivery devices to improve patient adherence.
✅ August 2025: FDA approved next-generation autoinjectors designed for self-administration of chronic disease medications.
Japan: Recent Industry Developments
✅ October 2025: Terumo Corporation launched smart injectable delivery systems with integrated digital tracking for dosage accuracy.
✅ September 2025: Japanese pharma companies collaborated on developing needle-free injection technologies to reduce patient discomfort.
✅ August 2025: Increased investments in biosimilar injectable formulations drove demand for improved delivery devices.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/injectable-drug-delivery-market?kb
Latest M&A
The pharma sector saw major M&A activities centered on injectable drug technologies, including Eli Lilly's acquisition of Verve Therapeutics for $1 billion, expanding gene-editing and injectable cardiovascular therapies.
Pfizer's $10 billion acquisition of Metsera brought oral and injectable next-generation GLP-1 analogues into Pfizer's obesity and metabolic disease program.
Several CDMO/CDMO expansions focused on sterile injectables manufacturing capacity increased in 2025 to meet rising biologic drug injectable demand
Key Player:
Becton Dickinson & Company, Baxter International, Inc, Gerresheimer AG, Pfizer Inc, Schott AG, Terumo Corporation, SHL Medical, Owen Mumford, Ypsomed, Union Medico
Key Industry Developments:
In January 2024, Credence MedSystems, a leader in pharmaceutical drug delivery innovation, completed Factory Acceptance Testing (FAT) for its Companion injection device platform on a new Clinical Assembly Line.
In June 2023, Stevanato Group, S.p.A. launched Vertiva, an On-Body Delivery System (OBDS) designed for both basal and bolus injections across various subcutaneous therapies. Featuring a single-use pod with a pre-filled 3mL ISO cartridge and a reusable controller, Vertiva offers adaptable delivery profiles for small-molecule drugs and biologics, while emphasizing sustainability and cost-effectiveness.
Forecast Projection:
The global Injectable Drug Delivery market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.
Market Intelligence Research Process:
The Injectable Drug Delivery Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=injectable-drug-delivery-market?kb
Key Segmentations:
By Device Type: Autoinjectors, Conventional injection devices, Pen Injectors, Wearable injectors, Others
By Application: Oncology, Autoimmune Diseases, Hormonal Disorders, Orphan Disease, Others
By Usage Pattern: Curative Care, Immunization, Other Usage Pattern
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/injectable-drug-delivery-market?kb
FAQ's
Q1: How large is the Injectable Drug Delivery Market?
Ans: The Injectable Drug Delivery Market size was valued at US$ 744.3 million in 2024 and is projected to grow to US$ 1258.4 million by 2033.
Q2: How quickly is the Injectable Drug Delivery Market expanding?
Ans: The Injectable Drug Delivery Market is forecasted to grow at a CAGR of 5.8% between 2025 and 2032, showing Annual growth momentum
Q3: Which regions are dominating the Injectable Drug Delivery Market and which are fastest-growing?
Ans: North America dominating the Injectable Drug Delivery market.
Latest News & Product Launches
FDA cleared Signos Glucose Monitoring System, an AI-enabled continuous glucose monitor aimed at weight management via personalized lifestyle guidance, reflecting innovation in wearable injectable-related devices.
New injectable therapies targeting chronic conditions like diabetes, cancer, and autoimmune diseases continue to launch, emphasizing prefilled syringes, auto-injectors, and smart injectors.
Injectable biologics including GLP-1 receptor agonists, monoclonal antibodies, and gene therapies remain key drug classes driving the demand for innovative delivery systems.
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/injectable-drug-delivery-market?kb
FDA Approvals
Multiple new injectable biologics received FDA approval in 2025, including cancer therapies and metabolic drugs, expanding the portfolio of injectable drug delivery.
FDA novel drug therapy approvals also included new delivery systems optimizing patient adherence and dosing precision
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb
Reimbursement Trends
Reimbursement frameworks for injectable biologics improved in 2025, with CMS updating outpatient hospital drug reimbursement and physician fee schedules supporting coverage of more injectable specialty drugs.
Wellness reimbursement programs for wearable injectors and digital therapeutics integrating with injectables have expanded.
Cost and coverage of biosimilars and generics in injectable formats are becoming more competitive due to regulatory and pricing pressures
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Linkedin: https://www.linkedin.com/company/datam-intelligence/
Twitter: https://x.com/DataM_Research
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Injectable Drug Delivery Market to hit US$ 1258.4 million by 2033 | Top Companies are Becton Dickinson & Company, Baxter International, Inc, Gerresheimer AG, Pfizer Inc, Schott AG here
News-ID: 4261917 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
North America Lactic Acid Market to Grow at 16.03% CAGR through 2030, Driven by …
The North America lactic acid market is growing at a CAGR of 16.03% during the forecast period 2023-2030, according to DataM Intelligence. This remarkable growth is primarily fueled by rising demand for sustainable alternatives across various industries, particularly in bioplastics (PLA) and eco-friendly cleaning products.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/north-america-lactic-acid-market?jd
Recent Developments (November 2025)
✅ USDA Bio-Preferred Program Expansion - The U.S.…
US Research Antibodies Market Growth Forecast 2025-2035: Market Expected to Reac …
The Global Research Antibodies Market was valued at US$ 15.55 billion in 2024 and is projected to reach US$ 26.44 billion by 2033, growing at a CAGR of 6.08% during the forecast period. The market expansion is primarily driven by increasing investments in biotechnology and life sciences research, rising demand for antibodies in oncology and neurobiology, and technological advancements in recombinant and monoclonal antibody production.
Research antibodies play a pivotal role…
Japan Patient Engagement Solutions Market to hit US$ 16,167.26 Billion By 2033 | …
The Japan patient engagement solutions market reached US$ 2731.41 billion in 2024 and is expected to reach US$ 16,167.26 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.
According to DataM Intelligence Comprehensive Report has released its latest report on the "Japan Patient Engagement Solutions Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes…
Europe Medicinal Mushroom Market to Reach USD 22.15 Billion by 2032, Driven by I …
Europe's Medicinal Mushroom Market reached approximately US$ 10.45 billion in 2024 and is expected to reach around US$ 22.15 billion by 2032, growing at a CAGR of 9.85% during the forecast period 2025-2032, according to DataM Intelligence.
The market growth is driven by increasing consumer awareness of the health benefits of medicinal mushrooms, rising demand for natural immunity boosters, and continuous product launches in supplements and functional foods. Advancements in sustainable…
More Releases for Injectable
Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I …
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate?
The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes.
The small…
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In …
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028
The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis.
The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that…
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics…
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
